DQO: Catheter, Intravascular, Diagnostic
What it covers
An intravascular diagnostic catheter is a device used to record intracardiac pressures, to sample blood, and to introduce substances into the heart and vessels. Included in this generic device are right-heart catheters, left-heart catheters, and angiographic catheters, among others.
The identification in 21 CFR 870.1200, diagnostic intravascular catheter. FDA gives DQO no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261455 | Arterial Pressure Monitoring Set/Tray | Spectrum Vascular | Jun 26, 2026 | Traditional |
| K252702 | Bioptimal Pulmonary Artery Monitoring Catheter (TD2502NF, TD2502NGF, TD2502NDF, TD2502NCF, TD2502NCGF, TD2502NDGF, TD2502NDCF, TD2502NDCGF, TD2502NXCF, TD2502NDXF, TD2502NXCGF, TD2502NDXGF, TD2502NDXCF, TD2502NDXCGF, TD2502-110NF, TD2502-110NGF, TD2502-110NDF, TD2502-110NCF, TD2502-110NDGF, TD2502-110NDCF, TD2502-110NCGF, TD2502-110NDCGF, TD2502-110NXF, TD2502-110NXGF, TD2502-110NDXF, TD2502-110NXCF, TD2502-110NDXGF, TD2502-110NDXCF ,TD2502-110NXCGF, TD2502-110NDXCGF, TD2602NF, TD2602N | Bioptimal International Pte. , Ltd. | May 28, 2026 | Traditional |
| K254278 | Arterial Pressure Monitoring Set/Tray | Spectrum Vascular | Mar 25, 2026 | Special |
| K250751 | DualView Catheter | Terumo Corporation | Jul 17, 2025 | Traditional |
| K242966 | Gentuity® HF-OCT Imaging System with Vis-Rx Prime® Micro-Imaging Catheter | Gentuity, LLC | Jan 31, 2025 | Traditional |
| K242420 | pNOVUS 21 Microcatheter | Phenox, Ltd. | Nov 12, 2024 | Traditional |
| K233268 | Impress Angiographic Catheter | Merit Medical Systems, Inc. | May 22, 2024 | Special |
| K233975 | Zoom 6F Insert Catheters | Imperative Care, Inc. | Apr 2, 2024 | Traditional |
| K232536 | Soldier Microcatheter | Embolx, Inc. | Feb 23, 2024 | Traditional |
| K232573 | INFINITI Ambi Angiographic Catheter | Cordis US Corp | Nov 21, 2023 | Traditional |
Clearances by year
87 DQO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 3 | 85 |
| 2025 | 2 | 127 |
| 2024 | 4 | 148 |
| 2023 | 4 | 73 |
| 2022 | 4 | 181 |
| 2021 | 1 | 253 |
| 2020 | 3 | 30 |
| 2019 | 6 | 113 |
| 2018 | 10 | 234 |
| 2017 | 10 | 176 |
| 2016 | 4 | 89 |
| 2015 | 10 | 209 |
| 2014 | 3 | 109 |
| 2013 | 2 | 113 |
| 2012 | 15 | 94 |
| 2011 | 6 | 74 |
Who submits
46 applicants cleared a DQO device since 2011. 78% of the clearances went to applicants in United States, then Israel (6%), Japan (6%) and Ireland (3%). By type: Traditional 66%, Special 33% and Abbreviated 1%. 9 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Cook Incorporated | 10 |
| Surefire Medical, Inc. | 7 |
| AngioDynamics, Inc. | 5 |
| ABBOTT MEDICAL | 3 |
| Accurate Medical Therapeutics, Ltd. | 3 |
| Boston Scientific Corp | 3 |
| Concentric Medical, Inc. | 3 |
| Merit Medical Systems, Inc. | 3 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.1200.
Standards
21 CFR 870.1200 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DQO clearances declared.
Ask about DQO
Questions about DQO
What is FDA product code DQO?
Product code DQO, “Catheter, Intravascular, Diagnostic” in FDA's classification database, is a Class II device type under 21 CFR 870.1200 (diagnostic intravascular catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 501 clearances under DQO, 87 of them since 2011.
How many 510(k) clearances are there under DQO?
FDA’s 510(k) database listed 501 clearances under DQO as of Oct 29, 2026, 87 of them decided since 2011; the most recent decision was Jun 26, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DQO 510(k)?
For the 6 DQO clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 108 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DQO clearances?
Since 2011: Cook Incorporated (10), Surefire Medical, Inc. (7), AngioDynamics, Inc. (5), ABBOTT MEDICAL (3) and Accurate Medical Therapeutics, Ltd. (3). 46 applicants have cleared a DQO device in that time.